Rb, mc1-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer

Annals of Oncology

Volumn 12, Issue 6, 2001, Pages 779-785

  Backus, H H J ^a   Van Riel, J M G H ^a   Van Groeningen, C J ^a   Vos, W ^a   Dukers, D F ^a   Bloemena, E ^a   Wouters, D ^a   Pinedo, H M ^a   Peters, G J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

5 FU; Colorectal cancer; mcl 1; p53 and thymidylate synthase; Rb

Indexed keywords

CASPASE 3; FAS ANTIGEN; FAS LIGAND; FLUOROURACIL; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN MCL 1; PROTEIN P53; RETINOBLASTOMA PROTEIN; THYMIDYLATE SYNTHASE; CELL CYCLE PROTEIN; MCL1 PROTEIN; TUMOR PROTEIN;

ADULT; AGE; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG INFUSION; DRUG RESPONSE; FEMALE; GENDER; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR GROWTH; COLORECTAL TUMOR; COMPARATIVE STUDY; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; SURVIVAL;

ADULT; AGED; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYMIDYLATE SYNTHASE; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034743398     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011112227044     Document Type: Article

References (55)

1. Advanced colorectal cancer meta-analysis project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate
2. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer
3. Thymidylate synthase inhibition after administration of 5-fluorouracil with or without leucovorin; implications for treatment with 5-fluorouracil
4. Enhancement of the anti-tumor effects of 5-fluorouracil by folinic acid
5. Quantification of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin
6. P53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: An analysis of response and survival
7. Colorectal liver metastasis thymidylate synthase staining correlates with response to hepatic arterial floxuridine
8. Immunohistochemical quantification of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy
9. Thymidylate synthase protein expression in advanced colon cancer: Correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil
10. P53, cell cycle control and apoptosis: Implications for cancer
11. WAF1, a potential mediator of p53 tumor suppression
12. The retinoblastoma protein and cell cycle control
13. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes
14. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
15. Regulators of cell death
16. Mechanisms controlling cellular suicide: Role of bcl-2 and caspases
17. Apoptosis by death factor
18. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE
19. Caspase cleavage of Keratin 18 and reorganisation of intermediate filaments during epithelial cell apoptosis
20. The Fas death factor
21. Hepatic arterial 5-fluorouracil in patients with liver metastases of colorectal cancer: Single centre experience in 145 patients
22. Thymidylate synthase expression in patients with colorectal carcinoma using a polyclonal thymidylate synthase antibody in comparison to the TS 106 monoclonal antibody
23. Retinoblastoma protein in human breast carcinoma: Immunohistochemical study using a new monoclonal antibody effective on routinely processed tissues
24. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis
25. Structural and functional analysis of poly(ADP ribose) polymerase: An immunological study
26. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase
27. WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers
28. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme
29. FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas
30. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet derived endothelial cell growth factor, and proliferation markers in colorectal cancer
31. Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas
32. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum
33. Elevated expression of bcl-x and reduced bak in primary colorectal adenocarcinomas
34. Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2
35. Immunohistochemical analysis of mcl-1 protein in human tissues
36. 5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients
37. Catalyzed reporter deposition, a novel method of signal amplification. I. Application for immunoassays
38. P53 and Rb1 protein expression: Are they prognostically useful in colorectal cancer?
39. Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis
40. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas
41. P53 and thymidylate synthase expression in untreated stage II colon cancer: Associations with recurrence, survival, and site
42. Fas/Fas ligand interaction in human colorectal hepatic metastases
43. Prognostic significance of bcl-2, bcl-xL/S, bax and bak expressions in colorectal carcinomas
44. Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry
45. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease
46. Thymidylate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients
47. Rb1 protein in normal and malignant human colorectal tissue and colon cancer cell lines
48. Downstream molecular determinants of response to 5-fluorouracil and antifolate synthase inhibitors
49. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas
50. P53 nuclear protein overexpression in colorectal cancer: A dominant predictor of survival in patients with advanced hepatic metastases
51. P53 and PCNA expression in advanced colorectal cancer: Response to chemotherapy and long-term prognosis
52. P53 protein overexpression and response to biomodulated 5-fluorouracil chemotherapy in patients with advanced colorectal cancer
53. 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of bcl-2 family proteins
54. Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed
55. Bcl-2 expression and response to chemotherapy in colorectal adenocarcinomas